Skip to main content

MoneyWorks4Me

Oxygenta Pharmaceutical informs about disclosure

03 Oct 2024 Evaluate
Oxygenta Pharmaceutical has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for M V S Prasad Reddy & PACs.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1766.50
Dr. Reddys Labs. 1351.00
Cipla 1381.10
Lupin 2002.20
Zydus Lifesciences 1234.95
View more..